Shopping Cart

Expired activity

Please go to the PowerPak homepage and select a course.

Case 1: Gina is clinically stable, but she has new MRI lesions

Robert Bermel, MD
Staff Neurologist and Medical Director
Mellen Center for Multiple Sclerosis
Neurological Institute
Cleveland Clinic
Cleveland, OH

Case 2: Is Maggie's RRMS progressing?

Robert Fox, MD
Staff Neurologist
Mellen Center for Multiple Sclerosis
Neurological Institute
Cleveland Clinic
Cleveland, OH

Case 3: Is Sarah's MS inflammatory or progressive?

Mary Alissa Willis, MD
Staff Neurologist
Mellen Center for Multiple Sclerosis Treatment and Research
Neurological Institute
Cleveland Clinic
Cleveland, OH

Activity Director

Alexander D. Rae-Grant, MD
Clinical Associate Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Director of Resident and Student Education
Mellen Center for Multiple Sclerosis Treatment and Research
Cleveland Clinic
Cleveland, OH

Planning Committee

Le Hanh Hua, MD
Eric and Sheila Samson Chair for Multiple Sclerosis Research
Director, Mellen Program for MS
Cleveland Clinic Lou Ruvo Center for Brain Health
Cleveland Clinic
Las Vegas, NV

Kristin Helms, PharmD
Associate Clinical Professor
Pharmacy Practice
Auburn University
Harrison School of Pharmacy
Auburn, AL

FINANCIAL DISCLOSURE

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship which, in the context of their presentation, could be perceived as a potential conflict of interest:

ACCREDITATION STATEMENT

PHARMACY
The France Foundation is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education and will award 0.130 CEU for case 1 and 2 and 0.10 CEU for case 3 to pharmacists who complete the activity, complete the registration and evaluation forms, and successfully pass a posttest (>70%). There is no fee to participate in this activity. This is a knowledge educational activity. Your CE credits will be submitted electronically to the CPE Monitor. CE providers must upload participant information within 60 days from the date the participant completed the activity. Please submit all evaluations and credit requests no later than 30 days after you complete this activity to ensure your credit fulfillment, as CE credit cannot be awarded past 60 days from the activity date.

Cases 1 and 2:

UAN: 0391-9999-17-001-H01-P

Credits: 1.30 hour (0.130 CEU)
Published: January 31, 2017
Expires: January 30, 2018
Type of Activity: Knowledge
Media: Internet

Fee Information: There is no fee for this educational activity.

Estimated time to complete cases 1 and 2: 90 minutes

Case 3:

UAN: 0391-9999-17-002-H01-P

Credits: 1.0 hour (0.10 CEU)
Published: January 31, 2017
Expires: January 30, 2018
Type of Activity: Knowledge
Media: Internet

Fee Information: There is no fee for this educational activity.

Estimated time to complete case 3: 60 minutes

TARGET AUDIENCE

This accredited activity has been designed for pharmacists.

How to Earn Credit

During the period January 31, 2017 through January 30, 2018, participants must 1) read the learning objectives and faculty disclosures; 2) view the educational activity; and 3) complete the post-test and evaluation form directly after the activity within a maximum of 60 days of participating in the activity. If you successfully complete the post-test (score of 70% or higher) your credit will be uploaded into the CPE monitor within 30 days.

GOAL

Scientific and Practical Considerations for Individualized Treatment Selection for Patients with MS: An Innovative Patient-Centered Learning Experience is a webcast series that provides clinicians with evidence-based knowledge about assessing disease activity and progression, and inform individualized, optimal treatment selection, and communication strategies for patients with multiple sclerosis (MS).

EDUCATIONAL OBJECTIVES

Upon completion of this program, participants should be better able to:

1. Apply information on pharmacologic profiles to decisions to select or switch treatment
2. Select appropriate treatment options in response to the individual patient's characteristics and preferences
3. Demonstrate understanding of recommended approaches to monitoring disease progression
4. Apply patient engagement approaches and convey essential information for patients on treatment rationales and side effects in a timely and effective manner

REQUIRED COMPUTER HARDWARE/SOFTWARE

Please ensure the computer system you plan to use meets the following minimum requirements:

• Operating System: Windows 98 or higher & Macintosh 2.2 or higher
• Internet Browser (Mac &/ Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher & Opera 5 or higher
• Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
• Peripherals: Computer speakers or headphones
• Monitor Screen Resolution: 320 x 480 or higher
• Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint, Flash Player & HTML5

Disclosure of Unlabeled Use

TFF and Cleveland Clinic require CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF and Cleveland Clinic do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

Disclaimer

The France Foundation and Cleveland Clinic present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation, Cleveland Clinic and the commercial supporter(s) assume no liability for the information herein.

View Activity

Please note you will be taken to a secondary website for the content & posttest.